Literature DB >> 25311946

Mir-152 inhibits cell proliferation and colony formation of CD133(+) liver cancer stem cells by targeting KIT.

Haili Huang1, Min Hu, Peng Li, Caijie Lu, Mingyi Li.   

Abstract

miR152 is involved in diverse biological functions and development of disease. This study investigates the role of mir-152 in cell proliferation and colony formation of liver cancer stem cells. We show that exogenous overexpression of mir-152 suppresses cell proliferation and colony formation in CD133(+) hep3B cells. We also show that KIT is a direct target of miR-152 and miR-152 downregulates protein expression of KIT by directly binding to 3' untranslated region of KIT. Downregulation of KIT by specific siRNAs inhibits proliferation and colony formation of CD133(+) hep3B cells, which is similar to inhibitory effects of miR-152. Moreover, exogenous expression of KIT compromises inhibitory effects of miR-152 on cell proliferation and colony formation. Our findings suggest that mir-152 inhibits cell proliferation and colony formation of CD133(+) hep3B cells by targeting KIT.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25311946     DOI: 10.1007/s13277-014-2719-x

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  41 in total

1.  MiR-15b and miR-152 reduce glioma cell invasion and angiogenesis via NRP-2 and MMP-3.

Authors:  Xuguang Zheng; Michael Chopp; Yong Lu; Benjamin Buller; Feng Jiang
Journal:  Cancer Lett       Date:  2012-11-07       Impact factor: 8.679

2.  Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1.

Authors:  Jinfeng Huang; Yue Wang; Yingjun Guo; Shuhan Sun
Journal:  Hepatology       Date:  2010-07       Impact factor: 17.425

3.  MicroRNA-494 downregulates KIT and inhibits gastrointestinal stromal tumor cell proliferation.

Authors:  Won Kyu Kim; Misun Park; Young-Kook Kim; You Kwon Tae; Han-Kwang Yang; Jae Myun Lee; Hoguen Kim
Journal:  Clin Cancer Res       Date:  2011-10-31       Impact factor: 12.531

4.  Hepatic cancer stem cells and drug resistance: Relevance in targeted therapies for hepatocellular carcinoma.

Authors:  Caecilia Hc Sukowati; Natalia Rosso; Lory S Crocè; Claudio Tiribelli
Journal:  World J Hepatol       Date:  2010-03-27

5.  Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells.

Authors:  F Yu; H Deng; H Yao; Q Liu; F Su; E Song
Journal:  Oncogene       Date:  2010-05-24       Impact factor: 9.867

6.  Identification and characterization of tumorigenic liver cancer stem/progenitor cells.

Authors:  Stephanie Ma; Kwok-Wah Chan; Liang Hu; Terence Kin-Wah Lee; Jana Yim-Hung Wo; Irene Oi-Lin Ng; Bo-Jian Zheng; Xin-Yuan Guan
Journal:  Gastroenterology       Date:  2007-04-15       Impact factor: 22.682

7.  MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.

Authors:  Hongping Xia; London Lucien P J Ooi; Kam M Hui
Journal:  Hepatology       Date:  2013-06-25       Impact factor: 17.425

8.  Decreased c-kit function inhibits enhanced skin carcinogenesis in c-Ha-ras protooncogene transgenic mice.

Authors:  Satoru Muto; Motoya Katsuki; Shigeo Horie
Journal:  Cancer Sci       Date:  2007-08-07       Impact factor: 6.716

9.  MicroRNA-152 mediates DNMT1-regulated DNA methylation in the estrogen receptor α gene.

Authors:  Yung-Song Wang; Wen-Wen Chou; Ku-Chung Chen; Hsin-Yun Cheng; Ruey-Tay Lin; Suh-Hang Hank Juo
Journal:  PLoS One       Date:  2012-01-25       Impact factor: 3.240

10.  MiR-17-92 and miR-221/222 cluster members target KIT and ETV1 in human gastrointestinal stromal tumours.

Authors:  C M M Gits; P F van Kuijk; M B E Jonkers; A W M Boersma; W F van Ijcken; A Wozniak; R Sciot; P Rutkowski; P Schöffski; T Taguchi; R H J Mathijssen; J Verweij; S Sleijfer; M Debiec-Rychter; E A C Wiemer
Journal:  Br J Cancer       Date:  2013-08-22       Impact factor: 7.640

View more
  19 in total

Review 1.  MicroRNA regulation of liver cancer stem cells.

Authors:  Weiyang Lou; Jingxing Liu; Yanjia Gao; Guansheng Zhong; Bisha Ding; Liang Xu; Weimin Fan
Journal:  Am J Cancer Res       Date:  2018-07-01       Impact factor: 6.166

2.  MicroRNA-152 inhibits ovarian cancer cell proliferation and migration and may infer improved outcomes in ovarian cancer through targeting FOXP1.

Authors:  Wen Qin; Wei Xie; Qinglin He; Tianwei Sun; Chaoguo Meng; Kunling Yang; Yuanfu Luo; Dongmei Yang
Journal:  Exp Ther Med       Date:  2017-11-17       Impact factor: 2.447

3.  miR-152 down-regulation is associated with MET up-regulation in leiomyosarcoma and undifferentiated pleomorphic sarcoma.

Authors:  Laura Pazzaglia; Chiara Novello; Amalia Conti; Serena Pollino; Piero Picci; Maria Serena Benassi
Journal:  Cell Oncol (Dordr)       Date:  2016-11-29       Impact factor: 6.730

4.  MLF1 protein is a potential therapy target for lung adenocarcinoma.

Authors:  Xiaojun Li; Shengping Min; Hongtao Wang; Yuanbing Shen; Wei Li; Yuqing Chen; Xiaojing Wang
Journal:  Int J Clin Exp Pathol       Date:  2018-07-01

5.  Using miRNA-mRNA Interaction Analysis to Link Biologically Relevant miRNAs to Stem Cell Identity Testing for Next-Generation Culturing Development.

Authors:  Marian A E Crabbé; Kristel Gijbels; Aline Visser; David Craeye; Sara Walbers; Jef Pinxteren; Robert J Deans; Wim Annaert; Bart L T Vaes
Journal:  Stem Cells Transl Med       Date:  2016-04-13       Impact factor: 6.940

6.  Salvia-Nelumbinis Naturalis Formula Improved Inflammation in LPS Stressed Macrophages via Upregulating MicroRNA-152.

Authors:  Zansong Ma; Xiangbing Shu; Jie Huang; Haiyan Zhang; Zhen Xiao; Li Zhang
Journal:  Mediators Inflamm       Date:  2017-01-12       Impact factor: 4.711

7.  Sex and age differences in the expression of liver microRNAs during the life span of F344 rats.

Authors:  Joshua C Kwekel; Vikrant Vijay; Tao Han; Carrie L Moland; Varsha G Desai; James C Fuscoe
Journal:  Biol Sex Differ       Date:  2017-02-03       Impact factor: 5.027

8.  miR-152 functions as a tumor suppressor in colorectal cancer by targeting PIK3R3.

Authors:  Bo Li; Zhongshi Xie; Bai Li
Journal:  Tumour Biol       Date:  2016-01-28

9.  Salvianolic acid B-induced microRNA-152 inhibits liver fibrosis by attenuating DNMT1-mediated Patched1 methylation.

Authors:  Fujun Yu; Zhongqiu Lu; Bicheng Chen; Xiaoli Wu; Peihong Dong; Jianjian Zheng
Journal:  J Cell Mol Med       Date:  2015-08-10       Impact factor: 5.310

Review 10.  The Therapeutic Targets of miRNA in Hepatic Cancer Stem Cells.

Authors:  Sabrina Bimonte; Maddalena Leongito; Antonio Barbieri; Vitale Del Vecchio; Michela Falco; Aldo Giudice; Raffaele Palaia; Vittorio Albino; Raimondo Di Giacomo; Antonella Petrillo; Vincenza Granata; Francesco Izzo
Journal:  Stem Cells Int       Date:  2016-03-28       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.